Get started
Author

Hakan Bozkaya

Observed names: BOZKAYA, HAKAN, BOZKAYA, Hakan, Bozkaya, Hakan, H BOZKAYA, H Bozkaya, H. Bozkaya, HAKAN BOZKAYA, Hakan BOZKAYA
Institution: Ankara University
Observed institutions: Tulane University, Ministry of Health, University of Thessaly, Ankara University, University of Milan, Universidad de Buenos Aires, Hôpital Beaujon, Tulane Medical Center, Ruijin Hospital, Erasmus MC, Taipei Veterans General Hospital, Medizinische Hochschule Hannover, Ege University, Türkiye Yüksek İhtisas Hastanesi, Ankara Atatürk Eğitim ve Araştırma Hastanesi, Centre Hospitalier Universitaire Brugmann, University Hospital of Geneva, Istanbul University-Cerrahpaşa, Hospital Clínic de Barcelona, Hospital de Santo António, Beijing Ditan Hospital, National Yang Ming University, Kırıkkale University, Hacettepe University, Istanbul University, Gazi University
OpenAlex ID: A5110037973
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
2011 · Heiner Wedemeyer, Cihan Yurdaydìn, et al. · New England Journal of Medicine · 486
PDF
Natural history and treatment of chronic delta hepatitis
2010 · C. Yurdaydın, R. Idilman, et al. · Journal of Viral Hepatitis · 162
Cytotoxic CD4 + T cells in viral hepatitis
2006 · N. Aslan, C. Yurdaydin, et al. · Journal of Viral Hepatitis · 152
PDF
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
2008 · C. Yurdaydın, H. Bozkaya, et al. · Journal of Viral Hepatitis · 128
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis
2009 · Kalliopi Zachou, Cihan Yurdaydin, et al. · Liver International · 120
Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients
2004 · A. M. Bozdayı, N. Aslan, et al. · Archives of Virology · 118
Famciclovir treatment of chronic delta hepatitis
2002 · Cihan Yurdaydin, Hakan Bozkaya, et al. · Journal of Hepatology · 109
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
2018 · Cihan Yurdaydin, Onur Keskin, et al. · The Journal of Infectious Diseases · 93
PDF
Effects of vitamin E treatment on peroxisome proliferator‐activated receptor‐α expression and insulin resistance in patients with non‐alcoholic steatohepatitis: results of a pilot study
2007 · F Yakaryilmaz, S Guliter, et al. · Internal Medicine Journal · 75
Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis
2005 · Ozlem Erkan, Abdurrahman M. Bozdayi, et al. · European Journal of Gastroenterology & Hepatology · 69
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
2015 · Onur Keskin, Heiner Wedemeyer, et al. · Clinical Gastroenterology and Hepatology · 66
Risk Factors for Hepatocellular Carcinoma in Turkey
2001 · Özden Uzunalimoğlu, Cihan Yurdaydin, et al. · Digestive Diseases and Sciences · 66
A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis
2007 · C. Yurdaydın, H. Bozkaya, et al. · Journal of Viral Hepatitis · 64
Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis
2013 · Gokhan Yildiz, Ayca Arslan-Ergul, et al. · PLoS ONE · 62
PDF
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine
2003 · A. M. Bozdayi̇, Ö. Uzunalimoğlu, et al. · Journal of Viral Hepatitis · 57
Endoscopic Management of Biliary Parasitic Diseases
2009 · Mehmet Bektaş, Abdulkadir Dökmeci, et al. · Digestive Diseases and Sciences · 56
HB eAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome
2012 · Benjamin Heidrich, Beatriz C. Serrano, et al. · Liver International · 55
Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
2000 · H Bozkaya, M Bozdayi, et al. · PubMed · 55
High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection
1997 · Hakan Bozkaya, Ulus S. Akarca, et al. · Journal of Hepatology · 47
Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats
1999 · A Akbay, K Ĉinar, et al. · Human & Experimental Toxicology · 43
PDF
Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels
2001 · A.Mithat Bozdayı, Hakan Bozkaya, et al. · Journal of Clinical Virology · 41
The Characteristics and Clinical Outcome of Drug-induced Liver Injury
2010 · Ramazan Idilman, Mehmet Bektas, et al. · Journal of Clinical Gastroenterology · 40
Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B
2005 · C. Yurdaydin, H. Bozkaya, et al. · Journal of Viral Hepatitis · 34
Anti-Hdv Immunoglobulin M Testing in Hepatitis Delta Revisited: Correlations with Disease Activity and Response to Pegylated Interferon-α2A Treatment
2011 · Ingmar Mederacke, Cihan Yurdaydin, et al. · Antiviral Therapy · 32
Ligand‐induced expression of peroxisome proliferator‐activated receptor α and activation of fatty acid oxidation enzymes in fatty liver
2004 · F. Akbiyik, K. Cinar, et al. · European Journal of Clinical Investigation · 31
Works count: 144
Citation count: 2,874
H-index: 28
I10-index: 50
Year
Topic
Type